{
    "code": "02021919",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021919",
    "time": "2018-03-30 03:53:10",
    "許可證字號": "衛署藥輸字第021919號",
    "註銷狀態": "已註銷",
    "註銷日期": "104\/06\/29",
    "註銷理由": "自請註銷",
    "有效日期": "107\/02\/28",
    "發證日期": "86\/10\/15",
    "許可證種類": "製　劑",
    "舊證字號": "02015697",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202191902",
    "中文品名": "溶栓酉每凍晶注射劑７５０，０００單位",
    "英文品名": "STREPTASE 750,000I.U. LYOPHILIZED FOR INJECTION",
    "適應症": "血栓及栓塞之纖維溶解劑。",
    "劑型": "243凍晶注射劑",
    "包裝": "100小瓶盒裝 750000單位小瓶",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "STREPTOKINASE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0601501100  吉發企業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F470241000  CSL BEHRING GMBH",
        "製造廠廠址": "EMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANY",
        "製造廠公司地址": "EMIL-VON-BEHRING-STRASSE 76,35041, MARBURG,GERMANY (P.O. BOX)1230,D-35002 MARBURG, GERMANY"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2040000100",
            "成分名稱": "STREPTOKINASE",
            "含量描述": "",
            "含量": "750000.0000000000",
            "單位": "I.U."
        }
    ],
    "仿單外盒": [
        {
            "title": "020219190005___20130116.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021919&Seq=005&Type=9"
        },
        {
            "title": "020219190003___20130116.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021919&Seq=003&Type=8"
        }
    ]
}